Oral probiotic control skin inflammation by acting on both effector and regulatory T cells.

Oral probiotic control skin inflammation by acting on both effector and regulatory T cells.

Probiotics are believed to alleviate allergic and inflammatory skin disorders, but their impact on pathogenic effector T cells remains poorly documented. Here we show that oral treatment with the probiotic bacteria L. casei (DN-114 001) alone alleviates antigen-specific skin inflammation mediated by...

Full description

Bibliographic Details
Main Authors: Feriel Hacini-Rachinel, Hanane Gheit, Jean-Benoit Le Luduec, Fariel Dif, Stéphane Nancey, Dominique Kaiserlian
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2009-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2654141?pdf=render

Internet

http://europepmc.org/articles/PMC2654141?pdf=render

Similar Items